These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 32079034)

  • 1. Changing Landscape of Dravet Syndrome Management: An Overview.
    Samanta D
    Neuropediatrics; 2020 Apr; 51(2):135-145. PubMed ID: 32079034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic advances in Dravet syndrome: a targeted literature review.
    Strzelczyk A; Schubert-Bast S
    Expert Rev Neurother; 2020 Oct; 20(10):1065-1079. PubMed ID: 32799683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dravet Syndrome: A Review of Current Management.
    Wheless JW; Fulton SP; Mudigoudar BD
    Pediatr Neurol; 2020 Jun; 107():28-40. PubMed ID: 32165031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and safety of stiripentol, cannabidiol and fenfluramine as first-line add-on therapies for seizures in Dravet syndrome: A network meta-analysis.
    Guerrini R; Chiron C; Vandame D; Linley W; Toward T
    Epilepsia Open; 2024 Apr; 9(2):689-703. PubMed ID: 38427284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment-Refractory Dravet Syndrome: Considerations for Novel Medications.
    Lopez JC; Pare JR; Blackmer AB; Orth LE
    J Pediatr Health Care; 2022; 36(5):479-488. PubMed ID: 35987555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    Lattanzi S; Trinka E; Russo E; Del Giovane C; Matricardi S; Meletti S; Striano P; Damavandi PT; Silvestrini M; Brigo F
    Drugs; 2023 Oct; 83(15):1409-1424. PubMed ID: 37695433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for Dravet Syndrome.
    Wallace A; Wirrell E; Kenney-Jung DL
    Paediatr Drugs; 2016 Jun; 18(3):197-208. PubMed ID: 26966048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of the ketogenic diet in Dravet syndrome - Comparison with various standard antiepileptic drug regimen.
    Dressler A; Trimmel-Schwahofer P; Reithofer E; Mühlebner A; Gröppel G; Reiter-Fink E; Benninger F; Grassl R; Feucht M
    Epilepsy Res; 2015 Jan; 109():81-9. PubMed ID: 25524846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stiripentol for the treatment of seizures in Dravet syndrome.
    Eschbach K; Knupp KG
    Expert Rev Clin Pharmacol; 2019 May; 12(5):379-388. PubMed ID: 31017478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dravet syndrome: Advances in etiology, clinical presentation, and treatment.
    He Z; Li Y; Zhao X; Li B
    Epilepsy Res; 2022 Dec; 188():107041. PubMed ID: 36368227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for the treatment of Dravet syndrome.
    Brigo F; Striano P; Balagura G; Belcastro V
    Expert Opin Emerg Drugs; 2018 Dec; 23(4):261-269. PubMed ID: 30482063
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent Advances in the Drug Treatment of Dravet Syndrome.
    Wirrell EC; Nabbout R
    CNS Drugs; 2019 Sep; 33(9):867-881. PubMed ID: 31549357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of an antisense knockdown zebrafish model of Dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramine.
    Zhang Y; Kecskés A; Copmans D; Langlois M; Crawford AD; Ceulemans B; Lagae L; de Witte PA; Esguerra CV
    PLoS One; 2015; 10(5):e0125898. PubMed ID: 25965391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stiripentol for the treatment of seizures associated with Dravet syndrome.
    Chiron C
    Expert Rev Neurother; 2019 Apr; 19(4):301-310. PubMed ID: 30900478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Dravet Syndrome.
    Wirrell EC
    Can J Neurol Sci; 2016 Jun; 43 Suppl 3():S13-8. PubMed ID: 27264138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do children with Dravet syndrome continue to benefit from stiripentol for long through adulthood?
    Chiron C; Helias M; Kaminska A; Laroche C; de Toffol B; Dulac O; Nabbout R; An I
    Epilepsia; 2018 Sep; 59(9):1705-1717. PubMed ID: 30132836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current therapeutic procedures in Dravet syndrome.
    Chiron C
    Dev Med Child Neurol; 2011 Apr; 53 Suppl 2():16-8. PubMed ID: 21504427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dravet syndrome: Treatment options and management of prolonged seizures.
    Cross JH; Caraballo RH; Nabbout R; Vigevano F; Guerrini R; Lagae L
    Epilepsia; 2019 Dec; 60 Suppl 3():S39-S48. PubMed ID: 31904119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stiripentol: A Review in Dravet Syndrome.
    Frampton JE
    Drugs; 2019 Nov; 79(16):1785-1796. PubMed ID: 31617141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stiripentol (Diacomit) for Dravet syndrome.
    Med Lett Drugs Ther; 2021 Mar; 63(1620):e48-e50. PubMed ID: 33976090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.